| abstract |
The present invention provides novel tetrahydronaphthalene derivatives according to the following formulas, in one embodiment (insertions B, A, I, C and E) described herein, and their pharmaceutically acceptable compounds: Regarding salt. The invention also provides for the use of such compositions in compositions comprising the compounds of the invention and methods of treating diseases and conditions that are beneficially treated by administering selective T-type calcium channel blockers. |